Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Up 300.0% in November

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 400 shares, an increase of 300.0% from the November 15th total of 100 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is presently 0.1 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of HROWM traded up $0.01 during trading hours on Friday, hitting $26.20. 2,652 shares of the company were exchanged, compared to its average volume of 4,006. The firm’s 50 day moving average is $26.33 and its 200-day moving average is $26.39. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52 week low of $25.03 and a 52 week high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th were paid a dividend of $0.7422 per share. The ex-dividend date of this dividend was Tuesday, October 15th. This represents a $2.97 annualized dividend and a dividend yield of 11.33%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.